Faron Pharmaceuticals Oy (GB:FARN) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Faron Pharmaceuticals Oy is set to host an engaging Capital Markets Day on October 22, 2024, featuring discussions on the company’s strategic focuses and the latest clinical data for its leading immunotherapy drug bexmarilimab. The event will present insights on updated survival data from the BEXMAB trial, market research in myelodysplastic syndrome (MDS), and the development plan for solid tumors. This hybrid event promises to provide investors with valuable updates and an introduction to the new Scientific Advisory Board, with options for both live and webcast attendance.
For further insights into GB:FARN stock, check out TipRanks’ Stock Analysis page.